

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 9.45436747 |
| 2 | actin-myosin filament sliding (GO:0033275) | 9.45436747 |
| 3 | protoporphyrinogen IX metabolic process (GO:0046501) | 8.48893867 |
| 4 | actin-mediated cell contraction (GO:0070252) | 7.66790777 |
| 5 | oxygen transport (GO:0015671) | 7.29222605 |
| 6 | skeletal muscle contraction (GO:0003009) | 7.02539014 |
| 7 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 6.99264747 |
| 8 | gas transport (GO:0015669) | 6.91830561 |
| 9 | regulation of skeletal muscle contraction (GO:0014819) | 6.88389712 |
| 10 | regulation of relaxation of muscle (GO:1901077) | 6.51556737 |
| 11 | striated muscle contraction (GO:0006941) | 6.25842474 |
| 12 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.02697149 |
| 13 | * porphyrin-containing compound biosynthetic process (GO:0006779) | 5.84556646 |
| 14 | response to inactivity (GO:0014854) | 5.73476510 |
| 15 | actin filament-based movement (GO:0030048) | 5.63085690 |
| 16 | creatine metabolic process (GO:0006600) | 5.31229902 |
| 17 | * tetrapyrrole biosynthetic process (GO:0033014) | 5.21470815 |
| 18 | sodium ion export (GO:0071436) | 5.09557494 |
| 19 | receptor recycling (GO:0001881) | 5.03056369 |
| 20 | heme biosynthetic process (GO:0006783) | 4.94642841 |
| 21 | response to methylmercury (GO:0051597) | 4.88405198 |
| 22 | locomotory exploration behavior (GO:0035641) | 4.67813509 |
| 23 | synaptic vesicle maturation (GO:0016188) | 4.66304573 |
| 24 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.62734022 |
| 25 | cardiac muscle hypertrophy (GO:0003300) | 4.55645593 |
| 26 | actomyosin structure organization (GO:0031032) | 4.52212124 |
| 27 | erythrocyte development (GO:0048821) | 4.51548426 |
| 28 | skeletal muscle adaptation (GO:0043501) | 4.51148480 |
| 29 | regulation of actin filament-based movement (GO:1903115) | 4.44497598 |
| 30 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.40828920 |
| 31 | striated muscle hypertrophy (GO:0014897) | 4.38136479 |
| 32 | muscle contraction (GO:0006936) | 4.35271822 |
| 33 | * porphyrin-containing compound metabolic process (GO:0006778) | 4.34215878 |
| 34 | regulation of ARF protein signal transduction (GO:0032012) | 4.28723854 |
| 35 | response to insecticide (GO:0017085) | 4.26733489 |
| 36 | skeletal muscle fiber development (GO:0048741) | 4.22727282 |
| 37 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.17901077 |
| 38 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.14248010 |
| 39 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.10836787 |
| 40 | regulation of response to osmotic stress (GO:0047484) | 4.10235743 |
| 41 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.05453081 |
| 42 | erythrocyte maturation (GO:0043249) | 4.02120182 |
| 43 | myotube cell development (GO:0014904) | 3.96694591 |
| 44 | muscle system process (GO:0003012) | 3.94766030 |
| 45 | muscle hypertrophy (GO:0014896) | 3.90422120 |
| 46 | cell communication by electrical coupling (GO:0010644) | 3.90119520 |
| 47 | striated muscle adaptation (GO:0014888) | 3.89126777 |
| 48 | response to muscle activity (GO:0014850) | 3.88416752 |
| 49 | negative regulation of organelle assembly (GO:1902116) | 3.81494148 |
| 50 | vocalization behavior (GO:0071625) | 3.80615694 |
| 51 | regulation of synapse structural plasticity (GO:0051823) | 3.79303835 |
| 52 | iron ion import (GO:0097286) | 3.76151299 |
| 53 | neuronal action potential propagation (GO:0019227) | 3.76059743 |
| 54 | glycine transport (GO:0015816) | 3.74224953 |
| 55 | cellular potassium ion homeostasis (GO:0030007) | 3.71401888 |
| 56 | regulation of striated muscle contraction (GO:0006942) | 3.65625936 |
| 57 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.65116217 |
| 58 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.64964857 |
| 59 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.63568903 |
| 60 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.58546026 |
| 61 | activation of protein kinase A activity (GO:0034199) | 3.58478287 |
| 62 | positive regulation of fibroblast migration (GO:0010763) | 3.57731350 |
| 63 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.54547001 |
| 64 | heme metabolic process (GO:0042168) | 3.54544400 |
| 65 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.51357531 |
| 66 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.50714794 |
| 67 | potassium ion import (GO:0010107) | 3.43760511 |
| 68 | myeloid cell development (GO:0061515) | 3.43025213 |
| 69 | plasma membrane repair (GO:0001778) | 3.41610992 |
| 70 | skeletal muscle tissue regeneration (GO:0043403) | 3.41274409 |
| 71 | muscle fiber development (GO:0048747) | 3.40884035 |
| 72 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.38230834 |
| 73 | striated muscle atrophy (GO:0014891) | 3.38201305 |
| 74 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.38155985 |
| 75 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.37961132 |
| 76 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.37878965 |
| 77 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.33514503 |
| 78 | muscle hypertrophy in response to stress (GO:0003299) | 3.33514503 |
| 79 | cardiac muscle adaptation (GO:0014887) | 3.33514503 |
| 80 | synaptic vesicle exocytosis (GO:0016079) | 3.31927670 |
| 81 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.31446842 |
| 82 | cell communication involved in cardiac conduction (GO:0086065) | 3.30857682 |
| 83 | skeletal muscle tissue development (GO:0007519) | 3.30849468 |
| 84 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.30806207 |
| 85 | membrane depolarization during action potential (GO:0086010) | 3.29416133 |
| 86 | neuromuscular process controlling balance (GO:0050885) | 3.29123388 |
| 87 | cardiac muscle contraction (GO:0060048) | 3.28122792 |
| 88 | adult heart development (GO:0007512) | 3.27730407 |
| 89 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.27587076 |
| 90 | glutamate secretion (GO:0014047) | 3.27325644 |
| 91 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.26369540 |
| 92 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.25947415 |
| 93 | cellular response to dexamethasone stimulus (GO:0071549) | 3.23262400 |
| 94 | carnitine transmembrane transport (GO:1902603) | 3.23078755 |
| 95 | glycogen catabolic process (GO:0005980) | 3.21837951 |
| 96 | long-term memory (GO:0007616) | 3.21337445 |
| 97 | negative regulation of potassium ion transport (GO:0043267) | 3.20128323 |
| 98 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.19657952 |
| 99 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.19417010 |
| 100 | cardiac myofibril assembly (GO:0055003) | 3.18716505 |
| 101 | regulation of synaptic vesicle transport (GO:1902803) | 3.16828946 |
| 102 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.16609220 |
| 103 | muscle adaptation (GO:0043500) | 3.16278945 |
| 104 | neurotransmitter secretion (GO:0007269) | 3.15780103 |
| 105 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.15560720 |
| 106 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.14768444 |
| 107 | glutamate receptor signaling pathway (GO:0007215) | 3.13909168 |
| 108 | platelet formation (GO:0030220) | 3.12855278 |
| 109 | carnitine shuttle (GO:0006853) | 3.12340822 |
| 110 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.11302366 |
| 111 | hemoglobin metabolic process (GO:0020027) | 3.10907236 |
| 112 | muscle tissue morphogenesis (GO:0060415) | 3.10828325 |
| 113 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.10127972 |
| 114 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.10127972 |
| 115 | exploration behavior (GO:0035640) | 3.09543658 |
| 116 | positive regulation of myotube differentiation (GO:0010831) | 3.08575889 |
| 117 | regulation of membrane repolarization (GO:0060306) | 3.08387295 |
| 118 | glucan catabolic process (GO:0009251) | 3.07897225 |
| 119 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.06629357 |
| 120 | myofibril assembly (GO:0030239) | 3.06122537 |
| 121 | positive regulation of synapse maturation (GO:0090129) | 3.05761945 |
| 122 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.05011881 |
| 123 | fatty acid transmembrane transport (GO:1902001) | 3.04984314 |
| 124 | neuromuscular process controlling posture (GO:0050884) | 3.03233249 |
| 125 | response to epinephrine (GO:0071871) | 3.01047660 |
| 126 | * tetrapyrrole metabolic process (GO:0033013) | 3.00991014 |
| 127 | import into cell (GO:0098657) | 3.00249112 |
| 128 | synaptic transmission, glutamatergic (GO:0035249) | 2.99953422 |
| 129 | sarcomere organization (GO:0045214) | 2.99754974 |
| 130 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.99222159 |
| 131 | gamma-aminobutyric acid transport (GO:0015812) | 2.96583544 |
| 132 | protein targeting to plasma membrane (GO:0072661) | 2.95906047 |
| 133 | cardiac muscle cell development (GO:0055013) | 2.95463753 |
| 134 | glucan biosynthetic process (GO:0009250) | 2.95096447 |
| 135 | glycogen biosynthetic process (GO:0005978) | 2.95096447 |
| 136 | response to dexamethasone (GO:0071548) | 2.94877248 |
| 137 | NADH metabolic process (GO:0006734) | 2.94210570 |
| 138 | muscle cell cellular homeostasis (GO:0046716) | 2.93305710 |
| 139 | cerebellar granule cell differentiation (GO:0021707) | 2.92838428 |
| 140 | layer formation in cerebral cortex (GO:0021819) | 2.92746638 |
| 141 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.92088699 |
| 142 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.92088699 |
| 143 | regulation of the force of heart contraction (GO:0002026) | 2.90992912 |
| 144 | cellular response to epinephrine stimulus (GO:0071872) | 2.90288379 |
| 145 | amino-acid betaine transport (GO:0015838) | 2.89947496 |
| 146 | carnitine transport (GO:0015879) | 2.89947496 |
| 147 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.89708394 |
| 148 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.88666446 |
| 149 | erythrocyte differentiation (GO:0030218) | 2.88008929 |
| 150 | * actin filament capping (GO:0051693) | 2.86601772 |
| 151 | regulation of cell communication by electrical coupling (GO:0010649) | 2.86195759 |
| 152 | response to lead ion (GO:0010288) | 2.82057033 |
| 153 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.81977591 |
| 154 | neuron-neuron synaptic transmission (GO:0007270) | 2.81336158 |
| 155 | bicarbonate transport (GO:0015701) | 2.80701854 |
| 156 | synaptic vesicle endocytosis (GO:0048488) | 2.79430340 |
| 157 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.76555541 |
| 158 | cell differentiation in hindbrain (GO:0021533) | 2.75377601 |
| 159 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.74528523 |
| 160 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.73372913 |
| 161 | protein localization to synapse (GO:0035418) | 2.71390453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 5.83637127 |
| 2 | GATA1_19941826_ChIP-Seq_K562_Human | 4.15426417 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.05792170 |
| 4 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 3.34147424 |
| 5 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 3.01968709 |
| 6 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 2.94226940 |
| 7 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.91179198 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.73076382 |
| 9 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.55369464 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.38038238 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.37188098 |
| 12 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.36430968 |
| 13 | KDM2B_26808549_Chip-Seq_K562_Human | 2.22030830 |
| 14 | * GATA2_19941826_ChIP-Seq_K562_Human | 2.19544407 |
| 15 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.18817809 |
| 16 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.09976277 |
| 17 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.06523696 |
| 18 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.02697660 |
| 19 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.99555486 |
| 20 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.98949725 |
| 21 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.96953490 |
| 22 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.91032367 |
| 23 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.88177810 |
| 24 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.88141049 |
| 25 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.87285382 |
| 26 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.86555167 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.84223309 |
| 28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.82600154 |
| 29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.80417529 |
| 30 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.79032271 |
| 31 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.75504492 |
| 32 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.72651539 |
| 33 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.72317465 |
| 34 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.72317465 |
| 35 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.70055627 |
| 36 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.65889807 |
| 37 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.62548047 |
| 38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.59209967 |
| 39 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.58043051 |
| 40 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.55776543 |
| 41 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50248100 |
| 42 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48782377 |
| 43 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.46915235 |
| 44 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.44987120 |
| 45 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.44957397 |
| 46 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.43312958 |
| 47 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.39831804 |
| 48 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.38448151 |
| 49 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.36955958 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35499169 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.34327453 |
| 52 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.31181040 |
| 53 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.29079347 |
| 54 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25666392 |
| 55 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.23421156 |
| 56 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.23330759 |
| 57 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.22842303 |
| 58 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.22349200 |
| 59 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.21797476 |
| 60 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.21026347 |
| 61 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.19994623 |
| 62 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.19919813 |
| 63 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.19693093 |
| 64 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18260029 |
| 65 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.17749244 |
| 66 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.17649453 |
| 67 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17320399 |
| 68 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.15691047 |
| 69 | P68_20966046_ChIP-Seq_HELA_Human | 1.15666186 |
| 70 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.14532937 |
| 71 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.14358886 |
| 72 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.12795474 |
| 73 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12297367 |
| 74 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.12029688 |
| 75 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10337742 |
| 76 | AR_19668381_ChIP-Seq_PC3_Human | 1.09761480 |
| 77 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.09164362 |
| 78 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.08843207 |
| 79 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.08370094 |
| 80 | SPI1_23127762_ChIP-Seq_K562_Human | 1.08163104 |
| 81 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.08055013 |
| 82 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.06277485 |
| 83 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.04342506 |
| 84 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03863931 |
| 85 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.02939496 |
| 86 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.02007877 |
| 87 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.01958022 |
| 88 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.01690972 |
| 89 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.01641613 |
| 90 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.01158289 |
| 91 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.00842153 |
| 92 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.00842153 |
| 93 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.99927739 |
| 94 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98410654 |
| 95 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98306901 |
| 96 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.97692277 |
| 97 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.97399146 |
| 98 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.97257715 |
| 99 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.95440604 |
| 100 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.95002310 |
| 101 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94657900 |
| 102 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.94149570 |
| 103 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.93504096 |
| 104 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.93443631 |
| 105 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.92874813 |
| 106 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.92474960 |
| 107 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.91947090 |
| 108 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.91898383 |
| 109 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.90188296 |
| 110 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.90082941 |
| 111 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.89963924 |
| 112 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.88965084 |
| 113 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86697920 |
| 114 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.86111408 |
| 115 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.85946626 |
| 116 | MYC_22102868_ChIP-Seq_BL_Human | 0.84874557 |
| 117 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.83771343 |
| 118 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.83129667 |
| 119 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.81065918 |
| 120 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.80058215 |
| 121 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79514192 |
| 122 | * FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.79185033 |
| 123 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.77669495 |
| 124 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.75049323 |
| 125 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.74340821 |
| 126 | MAF_26560356_Chip-Seq_TH1_Human | 0.74071996 |
| 127 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.73802367 |
| 128 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.72726706 |
| 129 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.72202918 |
| 130 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.71878740 |
| 131 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.70460597 |
| 132 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.69998578 |
| 133 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.69203117 |
| 134 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.69158983 |
| 135 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.69032647 |
| 136 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.67924415 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003656_abnormal_erythrocyte_physiolo | 6.15928154 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 5.42332025 |
| 3 | MP0004147_increased_porphyrin_level | 5.28562070 |
| 4 | MP0003646_muscle_fatigue | 3.03979853 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 2.95353918 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 2.88204104 |
| 7 | MP0000751_myopathy | 2.80312367 |
| 8 | MP0004215_abnormal_myocardial_fiber | 2.69893278 |
| 9 | MP0000749_muscle_degeneration | 2.52877143 |
| 10 | MP0005451_abnormal_body_composition | 2.52692037 |
| 11 | MP0009046_muscle_twitch | 2.52540599 |
| 12 | MP0004145_abnormal_muscle_electrophysio | 2.51271510 |
| 13 | MP0002822_catalepsy | 2.41648975 |
| 14 | MP0004084_abnormal_cardiac_muscle | 2.32332988 |
| 15 | MP0009745_abnormal_behavioral_response | 2.31553772 |
| 16 | MP0005083_abnormal_biliary_tract | 2.29108763 |
| 17 | MP0002064_seizures | 2.21898510 |
| 18 | MP0008569_lethality_at_weaning | 2.16845565 |
| 19 | MP0002063_abnormal_learning/memory/cond | 2.14864537 |
| 20 | MP0004270_analgesia | 2.14130814 |
| 21 | MP0003880_abnormal_central_pattern | 2.10567090 |
| 22 | MP0004036_abnormal_muscle_relaxation | 2.03994103 |
| 23 | MP0008775_abnormal_heart_ventricle | 2.01155713 |
| 24 | MP0001440_abnormal_grooming_behavior | 1.84143942 |
| 25 | MP0002272_abnormal_nervous_system | 1.80453285 |
| 26 | MP0001968_abnormal_touch/_nociception | 1.79943471 |
| 27 | MP0000747_muscle_weakness | 1.69835571 |
| 28 | MP0002734_abnormal_mechanical_nocicepti | 1.68829712 |
| 29 | MP0004484_altered_response_of | 1.65214480 |
| 30 | MP0004087_abnormal_muscle_fiber | 1.62956984 |
| 31 | MP0005423_abnormal_somatic_nervous | 1.61652916 |
| 32 | MP0002572_abnormal_emotion/affect_behav | 1.61408804 |
| 33 | MP0004130_abnormal_muscle_cell | 1.60317556 |
| 34 | MP0003137_abnormal_impulse_conducting | 1.58615121 |
| 35 | MP0005620_abnormal_muscle_contractility | 1.58323816 |
| 36 | MP0005330_cardiomyopathy | 1.55627059 |
| 37 | MP0004510_myositis | 1.55079452 |
| 38 | MP0004085_abnormal_heartbeat | 1.51981854 |
| 39 | MP0002972_abnormal_cardiac_muscle | 1.45581719 |
| 40 | MP0002067_abnormal_sensory_capabilities | 1.44908681 |
| 41 | MP0002909_abnormal_adrenal_gland | 1.44885824 |
| 42 | MP0002735_abnormal_chemical_nociception | 1.43087986 |
| 43 | MP0002269_muscular_atrophy | 1.42605121 |
| 44 | MP0001486_abnormal_startle_reflex | 1.41403020 |
| 45 | MP0002106_abnormal_muscle_physiology | 1.40191133 |
| 46 | MP0003879_abnormal_hair_cell | 1.39739515 |
| 47 | MP0008872_abnormal_physiological_respon | 1.38467943 |
| 48 | MP0000759_abnormal_skeletal_muscle | 1.37704591 |
| 49 | MP0004811_abnormal_neuron_physiology | 1.36503112 |
| 50 | MP0002108_abnormal_muscle_morphology | 1.35426671 |
| 51 | MP0002736_abnormal_nociception_after | 1.34270182 |
| 52 | MP0003045_fibrosis | 1.34167375 |
| 53 | MP0000733_abnormal_muscle_development | 1.32537998 |
| 54 | MP0001661_extended_life_span | 1.27507316 |
| 55 | MP0003787_abnormal_imprinting | 1.27010913 |
| 56 | MP0005386_behavior/neurological_phenoty | 1.26473617 |
| 57 | MP0004924_abnormal_behavior | 1.26473617 |
| 58 | MP0001970_abnormal_pain_threshold | 1.24150858 |
| 59 | MP0000013_abnormal_adipose_tissue | 1.21107529 |
| 60 | MP0004233_abnormal_muscle_weight | 1.19522592 |
| 61 | MP0003329_amyloid_beta_deposits | 1.18978555 |
| 62 | MP0004885_abnormal_endolymph | 1.18819523 |
| 63 | MP0005266_abnormal_metabolism | 1.17863675 |
| 64 | MP0002127_abnormal_cardiovascular_syste | 1.17141835 |
| 65 | MP0002733_abnormal_thermal_nociception | 1.16205540 |
| 66 | MP0005369_muscle_phenotype | 1.13389569 |
| 67 | MP0008961_abnormal_basal_metabolism | 1.12497168 |
| 68 | MP0003633_abnormal_nervous_system | 1.11335045 |
| 69 | MP0003950_abnormal_plasma_membrane | 1.08521339 |
| 70 | MP0002066_abnormal_motor_capabilities/c | 1.07518769 |
| 71 | MP0003221_abnormal_cardiomyocyte_apopto | 1.07418159 |
| 72 | MP0001501_abnormal_sleep_pattern | 1.06333699 |
| 73 | MP0009780_abnormal_chondrocyte_physiolo | 1.05353130 |
| 74 | MP0005385_cardiovascular_system_phenoty | 0.98852038 |
| 75 | MP0001544_abnormal_cardiovascular_syste | 0.98852038 |
| 76 | MP0000955_abnormal_spinal_cord | 0.98381850 |
| 77 | MP0002332_abnormal_exercise_endurance | 0.97510766 |
| 78 | MP0008770_decreased_survivor_rate | 0.96512493 |
| 79 | MP0003631_nervous_system_phenotype | 0.94227485 |
| 80 | MP0002229_neurodegeneration | 0.92456184 |
| 81 | MP0010630_abnormal_cardiac_muscle | 0.91859960 |
| 82 | MP0002557_abnormal_social/conspecific_i | 0.91805312 |
| 83 | MP0006036_abnormal_mitochondrial_physio | 0.90449727 |
| 84 | MP0002971_abnormal_brown_adipose | 0.88610416 |
| 85 | MP0006138_congestive_heart_failure | 0.88423406 |
| 86 | MP0002184_abnormal_innervation | 0.88322866 |
| 87 | MP0002882_abnormal_neuron_morphology | 0.87837543 |
| 88 | MP0004858_abnormal_nervous_system | 0.85593206 |
| 89 | MP0000003_abnormal_adipose_tissue | 0.83676190 |
| 90 | MP0006276_abnormal_autonomic_nervous | 0.82893703 |
| 91 | MP0004043_abnormal_pH_regulation | 0.82470240 |
| 92 | MP0001529_abnormal_vocalization | 0.80883095 |
| 93 | MP0004142_abnormal_muscle_tone | 0.80081352 |
| 94 | MP0005397_hematopoietic_system_phenotyp | 0.78573520 |
| 95 | MP0001545_abnormal_hematopoietic_system | 0.78573520 |
| 96 | MP0000750_abnormal_muscle_regeneration | 0.76172757 |
| 97 | MP0003075_altered_response_to | 0.74078473 |
| 98 | MP0002152_abnormal_brain_morphology | 0.72133691 |
| 99 | MP0008874_decreased_physiological_sensi | 0.69840933 |
| 100 | MP0005535_abnormal_body_temperature | 0.67609446 |
| 101 | MP0005167_abnormal_blood-brain_barrier | 0.64896547 |
| 102 | MP0005636_abnormal_mineral_homeostasis | 0.64543191 |
| 103 | MP0005310_abnormal_salivary_gland | 0.63235266 |
| 104 | MP0005666_abnormal_adipose_tissue | 0.62780970 |
| 105 | MP0000920_abnormal_myelination | 0.61561454 |
| 106 | MP0005646_abnormal_pituitary_gland | 0.61332076 |
| 107 | MP0000266_abnormal_heart_morphology | 0.61047439 |
| 108 | MP0003632_abnormal_nervous_system | 0.60941071 |
| 109 | MP0005375_adipose_tissue_phenotype | 0.60750901 |
| 110 | MP0003283_abnormal_digestive_organ | 0.59441629 |
| 111 | MP0004185_abnormal_adipocyte_glucose | 0.57931728 |
| 112 | MP0002090_abnormal_vision | 0.57373367 |
| 113 | MP0002877_abnormal_melanocyte_morpholog | 0.56966553 |
| 114 | MP0003828_pulmonary_edema | 0.55952147 |
| 115 | MP0009278_abnormal_bone_marrow | 0.53735975 |
| 116 | MP0008260_abnormal_autophagy | 0.51554725 |
| 117 | MP0008995_early_reproductive_senescence | 0.50482538 |
| 118 | MP0002638_abnormal_pupillary_reflex | 0.50036240 |
| 119 | MP0006035_abnormal_mitochondrial_morpho | 0.47205813 |
| 120 | MP0002078_abnormal_glucose_homeostasis | 0.46815875 |
| 121 | MP0003303_peritoneal_inflammation | 0.43541304 |
| 122 | MP0005187_abnormal_penis_morphology | 0.42444511 |
| 123 | MP0000372_irregular_coat_pigmentation | 0.38187571 |
| 124 | MP0001986_abnormal_taste_sensitivity | 0.35471221 |
| 125 | MP0005452_abnormal_adipose_tissue | 0.34814375 |
| 126 | MP0005670_abnormal_white_adipose | 0.33476161 |
| 127 | MP0002128_abnormal_blood_circulation | 0.31185634 |
| 128 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.30283263 |
| 129 | MP0003948_abnormal_gas_homeostasis | 0.28032757 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 9.12349173 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 8.91206948 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.81999227 |
| 4 | * Poikilocytosis (HP:0004447) | 6.92560047 |
| 5 | Type 1 muscle fiber predominance (HP:0003803) | 6.88879351 |
| 6 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 6.79038175 |
| 7 | Reticulocytosis (HP:0001923) | 6.33704718 |
| 8 | Distal arthrogryposis (HP:0005684) | 5.88577812 |
| 9 | Acanthocytosis (HP:0001927) | 5.75639434 |
| 10 | Myopathic facies (HP:0002058) | 5.30292744 |
| 11 | Focal seizures (HP:0007359) | 4.52049905 |
| 12 | Cholelithiasis (HP:0001081) | 4.47611833 |
| 13 | Round ear (HP:0100830) | 4.36086746 |
| 14 | Ulnar deviation of the wrist (HP:0003049) | 4.26687971 |
| 15 | Febrile seizures (HP:0002373) | 4.23215580 |
| 16 | Myokymia (HP:0002411) | 4.15413967 |
| 17 | Sudden death (HP:0001699) | 3.99146173 |
| 18 | Increased connective tissue (HP:0009025) | 3.98778948 |
| 19 | Exercise-induced myalgia (HP:0003738) | 3.96273964 |
| 20 | Focal motor seizures (HP:0011153) | 3.96199772 |
| 21 | Abnormal gallbladder morphology (HP:0012437) | 3.92815301 |
| 22 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.84955675 |
| 23 | Diaphragmatic weakness (HP:0009113) | 3.82378586 |
| 24 | Insomnia (HP:0100785) | 3.81782800 |
| 25 | Poor eye contact (HP:0000817) | 3.77527647 |
| 26 | Rhabdomyolysis (HP:0003201) | 3.75911283 |
| 27 | Epileptic encephalopathy (HP:0200134) | 3.71743806 |
| 28 | Neck muscle weakness (HP:0000467) | 3.69024112 |
| 29 | Dysmetric saccades (HP:0000641) | 3.68293060 |
| 30 | Calcaneovalgus deformity (HP:0001848) | 3.56580597 |
| 31 | Abnormal social behavior (HP:0012433) | 3.54671391 |
| 32 | Impaired social interactions (HP:0000735) | 3.54671391 |
| 33 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.53141616 |
| 34 | Visual hallucinations (HP:0002367) | 3.52932558 |
| 35 | Exercise-induced muscle cramps (HP:0003710) | 3.49996239 |
| 36 | Generalized tonic-clonic seizures (HP:0002069) | 3.47999164 |
| 37 | Depression (HP:0000716) | 3.42750117 |
| 38 | Fetal akinesia sequence (HP:0001989) | 3.42242471 |
| 39 | Rimmed vacuoles (HP:0003805) | 3.38475625 |
| 40 | Hemiparesis (HP:0001269) | 3.33508200 |
| 41 | Paralysis (HP:0003470) | 3.29258496 |
| 42 | Bundle branch block (HP:0011710) | 3.27962540 |
| 43 | Malignant hyperthermia (HP:0002047) | 3.23634150 |
| 44 | Action tremor (HP:0002345) | 3.22531962 |
| 45 | Abnormality of reticulocytes (HP:0004312) | 3.22036292 |
| 46 | Ventricular fibrillation (HP:0001663) | 3.18567157 |
| 47 | Calf muscle hypertrophy (HP:0008981) | 3.18359014 |
| 48 | Status epilepticus (HP:0002133) | 3.17954185 |
| 49 | Frequent falls (HP:0002359) | 3.15664506 |
| 50 | Deformed tarsal bones (HP:0008119) | 3.09557361 |
| 51 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.09299557 |
| 52 | Absent phalangeal crease (HP:0006109) | 3.03267257 |
| 53 | Lower limb amyotrophy (HP:0007210) | 2.94665169 |
| 54 | Polycythemia (HP:0001901) | 2.93694587 |
| 55 | Hypochromic microcytic anemia (HP:0004840) | 2.91580618 |
| 56 | Dysdiadochokinesis (HP:0002075) | 2.85914664 |
| 57 | Distal lower limb muscle weakness (HP:0009053) | 2.81584060 |
| 58 | Atrial fibrillation (HP:0005110) | 2.81095927 |
| 59 | Postural instability (HP:0002172) | 2.79548594 |
| 60 | Areflexia of lower limbs (HP:0002522) | 2.79178307 |
| 61 | Hyperkalemia (HP:0002153) | 2.77021356 |
| 62 | Muscle stiffness (HP:0003552) | 2.71370234 |
| 63 | Generalized muscle weakness (HP:0003324) | 2.70508589 |
| 64 | Anxiety (HP:0000739) | 2.69776257 |
| 65 | Progressive cerebellar ataxia (HP:0002073) | 2.69284882 |
| 66 | Difficulty running (HP:0009046) | 2.68629058 |
| 67 | Primary atrial arrhythmia (HP:0001692) | 2.68245998 |
| 68 | Prolonged QT interval (HP:0001657) | 2.67532231 |
| 69 | Abnormality of the calf musculature (HP:0001430) | 2.65442032 |
| 70 | Hyporeflexia of lower limbs (HP:0002600) | 2.59669263 |
| 71 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.56230022 |
| 72 | Subaortic stenosis (HP:0001682) | 2.56230022 |
| 73 | Supraventricular tachycardia (HP:0004755) | 2.54434746 |
| 74 | Abnormal finger flexion creases (HP:0006143) | 2.50750200 |
| 75 | Resting tremor (HP:0002322) | 2.50468084 |
| 76 | Abnormality of the gallbladder (HP:0005264) | 2.49876844 |
| 77 | Asymmetric septal hypertrophy (HP:0001670) | 2.49870077 |
| 78 | Gaze-evoked nystagmus (HP:0000640) | 2.48617940 |
| 79 | EMG: myopathic abnormalities (HP:0003458) | 2.47922365 |
| 80 | Supraventricular arrhythmia (HP:0005115) | 2.47244138 |
| 81 | Myotonia (HP:0002486) | 2.46158695 |
| 82 | Truncal ataxia (HP:0002078) | 2.44776998 |
| 83 | Cholecystitis (HP:0001082) | 2.41917006 |
| 84 | Abnormal gallbladder physiology (HP:0012438) | 2.41917006 |
| 85 | Microcytic anemia (HP:0001935) | 2.41490321 |
| 86 | Myoglobinuria (HP:0002913) | 2.39489339 |
| 87 | Abnormal hemoglobin (HP:0011902) | 2.37529035 |
| 88 | Long clavicles (HP:0000890) | 2.37078513 |
| 89 | Dilated cardiomyopathy (HP:0001644) | 2.36336411 |
| 90 | Muscle fiber splitting (HP:0003555) | 2.34305011 |
| 91 | Syncope (HP:0001279) | 2.33757971 |
| 92 | Toxemia of pregnancy (HP:0100603) | 2.32840148 |
| 93 | Diplopia (HP:0000651) | 2.31826484 |
| 94 | Abnormality of binocular vision (HP:0011514) | 2.31826484 |
| 95 | Abnormality of the foot musculature (HP:0001436) | 2.29572268 |
| 96 | Abnormal EKG (HP:0003115) | 2.28280421 |
| 97 | Lipoatrophy (HP:0100578) | 2.28003925 |
| 98 | Abnormality of the calcaneus (HP:0008364) | 2.27796433 |
| 99 | Heart block (HP:0012722) | 2.26978209 |
| 100 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.26110158 |
| 101 | Ankle clonus (HP:0011448) | 2.25580931 |
| 102 | Bulbar palsy (HP:0001283) | 2.24789124 |
| 103 | Foot dorsiflexor weakness (HP:0009027) | 2.23563689 |
| 104 | Absence seizures (HP:0002121) | 2.23426828 |
| 105 | Abnormality of the neuromuscular junction (HP:0003398) | 2.23184336 |
| 106 | Fatigable weakness (HP:0003473) | 2.23184336 |
| 107 | Abnormality of the lower motor neuron (HP:0002366) | 2.23139464 |
| 108 | Impaired smooth pursuit (HP:0007772) | 2.22514663 |
| 109 | Abnormal atrioventricular conduction (HP:0005150) | 2.21271216 |
| 110 | Ventricular arrhythmia (HP:0004308) | 2.21225896 |
| 111 | Global brain atrophy (HP:0002283) | 2.17989352 |
| 112 | Atonic seizures (HP:0010819) | 2.16491672 |
| 113 | Dysmetria (HP:0001310) | 2.16005901 |
| 114 | Dialeptic seizures (HP:0011146) | 2.12181843 |
| 115 | Intention tremor (HP:0002080) | 2.11176733 |
| 116 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.10983055 |
| 117 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.10770664 |
| 118 | Broad-based gait (HP:0002136) | 2.10502571 |
| 119 | Ventricular tachycardia (HP:0004756) | 2.10320625 |
| 120 | Weak cry (HP:0001612) | 2.09398740 |
| 121 | * Hyperbilirubinemia (HP:0002904) | 2.08399908 |
| 122 | Heterotopia (HP:0002282) | 2.05784487 |
| 123 | Supranuclear gaze palsy (HP:0000605) | 2.05609034 |
| 124 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.04786140 |
| 125 | Gowers sign (HP:0003391) | 2.04342578 |
| 126 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.02898832 |
| 127 | Increased variability in muscle fiber diameter (HP:0003557) | 2.02358820 |
| 128 | Bradykinesia (HP:0002067) | 2.01003532 |
| 129 | Osteomalacia (HP:0002749) | 1.99759218 |
| 130 | Distal lower limb amyotrophy (HP:0008944) | 1.99469247 |
| 131 | Severe muscular hypotonia (HP:0006829) | 1.98907207 |
| 132 | Tetraparesis (HP:0002273) | 1.98669059 |
| 133 | Atrioventricular block (HP:0001678) | 1.97697764 |
| 134 | Slender build (HP:0001533) | 1.96965393 |
| 135 | Hemiplegia (HP:0002301) | 1.94620347 |
| 136 | Muscular dystrophy (HP:0003560) | 1.94427353 |
| 137 | Scapular winging (HP:0003691) | 1.91632165 |
| 138 | EMG: neuropathic changes (HP:0003445) | 1.89074712 |
| 139 | Difficulty climbing stairs (HP:0003551) | 1.89053208 |
| 140 | Hypochromic anemia (HP:0001931) | 1.88553212 |
| 141 | Urinary urgency (HP:0000012) | 1.88449675 |
| 142 | Popliteal pterygium (HP:0009756) | 1.87045587 |
| 143 | Impaired vibratory sensation (HP:0002495) | 1.79338283 |
| 144 | Scanning speech (HP:0002168) | 1.78860135 |
| 145 | Childhood onset (HP:0011463) | 1.77123889 |
| 146 | Petechiae (HP:0000967) | 1.76471552 |
| 147 | Hip contracture (HP:0003273) | 1.75890315 |
| 148 | Nonprogressive disorder (HP:0003680) | 1.74772136 |
| 149 | Annular pancreas (HP:0001734) | 1.74534805 |
| 150 | Ileus (HP:0002595) | 1.67177708 |
| 151 | Metatarsus adductus (HP:0001840) | 1.66088200 |
| 152 | Type 2 muscle fiber atrophy (HP:0003554) | 1.64040918 |
| 153 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.59865303 |
| 154 | Proximal amyotrophy (HP:0007126) | 1.58928636 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.03468224 |
| 2 | EPHA4 | 2.74614719 |
| 3 | MAP2K3 | 2.71591053 |
| 4 | EIF2AK1 | 2.49659570 |
| 5 | DAPK2 | 2.33870496 |
| 6 | PHKG2 | 2.27970833 |
| 7 | PHKG1 | 2.27970833 |
| 8 | TAOK1 | 2.18854120 |
| 9 | MAP3K9 | 2.14311517 |
| 10 | TRIB3 | 2.09827928 |
| 11 | PIK3CG | 2.09312448 |
| 12 | CAMKK1 | 2.03531440 |
| 13 | MAP3K4 | 1.92718150 |
| 14 | PRKD3 | 1.86336217 |
| 15 | OBSCN | 1.77688922 |
| 16 | TRPM7 | 1.77505364 |
| 17 | LMTK2 | 1.76472933 |
| 18 | TTN | 1.74450952 |
| 19 | PAK6 | 1.70632787 |
| 20 | SGK3 | 1.70326675 |
| 21 | MINK1 | 1.64208316 |
| 22 | NEK1 | 1.62564301 |
| 23 | STK4 | 1.62159311 |
| 24 | RIPK1 | 1.62090383 |
| 25 | KSR2 | 1.61407839 |
| 26 | TAOK2 | 1.59026720 |
| 27 | STK38 | 1.57333694 |
| 28 | PINK1 | 1.49130371 |
| 29 | WNK1 | 1.48425778 |
| 30 | MUSK | 1.47338945 |
| 31 | SGK2 | 1.40919933 |
| 32 | RIPK4 | 1.36571395 |
| 33 | MAP2K4 | 1.32384433 |
| 34 | DMPK | 1.31855611 |
| 35 | SGK223 | 1.30221726 |
| 36 | SGK494 | 1.30221726 |
| 37 | PKN2 | 1.27884209 |
| 38 | CDK5 | 1.23968482 |
| 39 | BRSK1 | 1.23018330 |
| 40 | CAMKK2 | 1.20397606 |
| 41 | SGK1 | 1.20387703 |
| 42 | PRPF4B | 1.18301054 |
| 43 | CDC42BPA | 1.17083387 |
| 44 | PRKAA1 | 1.12836052 |
| 45 | MAP3K7 | 1.12702176 |
| 46 | NTRK1 | 1.08955629 |
| 47 | MARK1 | 1.07728355 |
| 48 | GRK5 | 1.04498451 |
| 49 | PRKCH | 1.04230666 |
| 50 | RET | 1.03928844 |
| 51 | SIK2 | 1.03524283 |
| 52 | NTRK2 | 1.03489002 |
| 53 | ALK | 1.02054004 |
| 54 | BMX | 1.01593852 |
| 55 | PDPK1 | 1.00636376 |
| 56 | EEF2K | 1.00424990 |
| 57 | CAMK1 | 0.97990642 |
| 58 | SCYL2 | 0.97765582 |
| 59 | UHMK1 | 0.97338729 |
| 60 | PDK1 | 0.97004271 |
| 61 | STK11 | 0.96192832 |
| 62 | CCNB1 | 0.96119029 |
| 63 | ICK | 0.93236401 |
| 64 | PTK2B | 0.92589943 |
| 65 | MAP2K7 | 0.88041073 |
| 66 | CAMK4 | 0.86848087 |
| 67 | RPS6KA3 | 0.85572886 |
| 68 | TNK2 | 0.82638657 |
| 69 | MAP3K3 | 0.79904876 |
| 70 | MAPKAPK3 | 0.79822527 |
| 71 | NME1 | 0.79764497 |
| 72 | KSR1 | 0.78855784 |
| 73 | DYRK1B | 0.78297411 |
| 74 | RPS6KA2 | 0.75270807 |
| 75 | DAPK1 | 0.72732396 |
| 76 | MAPK11 | 0.70216133 |
| 77 | CAMK1G | 0.69596886 |
| 78 | MAPK12 | 0.69253552 |
| 79 | CDK15 | 0.66968462 |
| 80 | PIM1 | 0.66309070 |
| 81 | PRKCG | 0.65112182 |
| 82 | JAK2 | 0.64905241 |
| 83 | CDK19 | 0.64575151 |
| 84 | AKT2 | 0.64508525 |
| 85 | MAP3K2 | 0.64404106 |
| 86 | MAP3K1 | 0.63581212 |
| 87 | ROCK1 | 0.62990640 |
| 88 | MAP3K13 | 0.62292181 |
| 89 | CDK18 | 0.62150773 |
| 90 | MAP2K6 | 0.62058736 |
| 91 | CDK12 | 0.59018454 |
| 92 | MARK3 | 0.58597302 |
| 93 | SYK | 0.58339009 |
| 94 | CDK14 | 0.58265156 |
| 95 | CDK11A | 0.57950978 |
| 96 | DAPK3 | 0.57539534 |
| 97 | CAMK2G | 0.57473575 |
| 98 | PRKD2 | 0.57449735 |
| 99 | MAP3K10 | 0.56994397 |
| 100 | RPS6KA5 | 0.56329392 |
| 101 | ERBB2 | 0.56002253 |
| 102 | PRKACG | 0.54713921 |
| 103 | RAF1 | 0.54713399 |
| 104 | MOS | 0.54312725 |
| 105 | MAPK13 | 0.54197101 |
| 106 | PRKAA2 | 0.53711591 |
| 107 | MARK2 | 0.53309017 |
| 108 | PDK4 | 0.52585791 |
| 109 | PDK3 | 0.52585791 |
| 110 | PRKD1 | 0.51758406 |
| 111 | MAP2K1 | 0.51495085 |
| 112 | TLK1 | 0.50672093 |
| 113 | TYRO3 | 0.50659740 |
| 114 | MAPK10 | 0.49785723 |
| 115 | ROCK2 | 0.49115432 |
| 116 | CAMK2A | 0.49044360 |
| 117 | ZAK | 0.47215285 |
| 118 | RPS6KL1 | 0.47102570 |
| 119 | MAP3K11 | 0.46974586 |
| 120 | RPS6KC1 | 0.46661867 |
| 121 | HIPK2 | 0.45255485 |
| 122 | BRAF | 0.44582132 |
| 123 | MAP3K5 | 0.43209691 |
| 124 | MAP3K6 | 0.42616830 |
| 125 | RPS6KA6 | 0.42536028 |
| 126 | RPS6KB1 | 0.42290291 |
| 127 | MAPK4 | 0.41866082 |
| 128 | PRKG1 | 0.40604613 |
| 129 | PKN1 | 0.40154679 |
| 130 | CAMK2D | 0.40144107 |
| 131 | PIK3CA | 0.40047739 |
| 132 | DYRK1A | 0.38627990 |
| 133 | GRK6 | 0.34937894 |
| 134 | PRKACA | 0.33084079 |
| 135 | CAMK2B | 0.31559703 |
| 136 | CLK1 | 0.31289378 |
| 137 | MAPK7 | 0.31143161 |
| 138 | MTOR | 0.25256038 |
| 139 | EPHA3 | 0.23152362 |
| 140 | AKT1 | 0.22640582 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.61224625 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.43186696 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.41213961 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.25956330 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.20853557 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.20360252 |
| 7 | Salivary secretion_Homo sapiens_hsa04970 | 2.13757754 |
| 8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.13446705 |
| 9 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.13300438 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.08151968 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.95077028 |
| 12 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.94831941 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 1.94537853 |
| 14 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.92402009 |
| 15 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.92312219 |
| 16 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.86108336 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.85348785 |
| 18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.70386011 |
| 19 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.67795860 |
| 20 | Insulin secretion_Homo sapiens_hsa04911 | 1.65394849 |
| 21 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.64845234 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.62516221 |
| 23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.61906110 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.61255946 |
| 25 | Alcoholism_Homo sapiens_hsa05034 | 1.58526294 |
| 26 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.52364543 |
| 27 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.51615339 |
| 28 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.47969733 |
| 29 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.47898607 |
| 30 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.43607572 |
| 31 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.38525458 |
| 32 | Renin secretion_Homo sapiens_hsa04924 | 1.34072800 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.30519226 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.29220267 |
| 35 | Long-term depression_Homo sapiens_hsa04730 | 1.28297401 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.27527375 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.27502989 |
| 38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.27056585 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.26499343 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.24227764 |
| 41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.24112884 |
| 42 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.23902162 |
| 43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.22993319 |
| 44 | Glioma_Homo sapiens_hsa05214 | 1.19929212 |
| 45 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.18803082 |
| 46 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.18078610 |
| 47 | Taste transduction_Homo sapiens_hsa04742 | 1.17495467 |
| 48 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.17380273 |
| 49 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.16740771 |
| 50 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.16549120 |
| 51 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.14835246 |
| 52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.11901341 |
| 53 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.06459544 |
| 54 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.05972363 |
| 55 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.05056291 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.01568135 |
| 57 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.00504820 |
| 58 | Cocaine addiction_Homo sapiens_hsa05030 | 1.00446746 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.98485016 |
| 60 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.95359118 |
| 61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.94547950 |
| 62 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.94458012 |
| 63 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93849923 |
| 64 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.93625978 |
| 65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.91877239 |
| 66 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.91801257 |
| 67 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.90551867 |
| 68 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.89769675 |
| 69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87473431 |
| 70 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.84255097 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83352460 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82870526 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80168392 |
| 74 | Bile secretion_Homo sapiens_hsa04976 | 0.79727540 |
| 75 | ABC transporters_Homo sapiens_hsa02010 | 0.78706456 |
| 76 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.78487185 |
| 77 | Circadian rhythm_Homo sapiens_hsa04710 | 0.76589346 |
| 78 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.75764462 |
| 79 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74617639 |
| 80 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.69533036 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.66840714 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65598643 |
| 83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64655694 |
| 84 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.64501375 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64216067 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.63518872 |
| 87 | Melanogenesis_Homo sapiens_hsa04916 | 0.62343133 |
| 88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61269997 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60608839 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60553821 |
| 91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.60014981 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59071803 |
| 93 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58678925 |
| 94 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.56900756 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53740423 |
| 96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51963878 |
| 97 | Platelet activation_Homo sapiens_hsa04611 | 0.51528936 |
| 98 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.51296238 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50540367 |
| 100 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50020351 |
| 101 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.47885628 |
| 102 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.47516249 |
| 103 | Focal adhesion_Homo sapiens_hsa04510 | 0.45846867 |
| 104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45072592 |
| 105 | Bladder cancer_Homo sapiens_hsa05219 | 0.44834903 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42891944 |
| 107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41718044 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41691077 |
| 109 | Lysine degradation_Homo sapiens_hsa00310 | 0.38300979 |
| 110 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.37437542 |
| 111 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37075070 |
| 112 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.32101824 |
| 113 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.30821599 |
| 114 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.29767883 |
| 115 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.29130983 |
| 116 | Tight junction_Homo sapiens_hsa04530 | 0.28951842 |

